Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14543886 | 0.86 | CA12 (0.31) | — | |
| SCHEMBL28884749 | 0.79 | ALDH1A1 (0.35) | ALDH1A1 | |
| Water SCHEMBL9507408 | 0.78 | CA1 (0.33) | — | |
| Formaldehyde SCHEMBL3043572 | 0.76 | CA1 (0.32) | — | |
| Hydroxyamine SCHEMBL11315924 | 0.76 | CA1 (0.32) | — | |
| SCHEMBL10996792 | 0.76 | ALDH1A1 (0.49) | ALDH1A1 | |
| SCHEMBL4640674 | 0.76 | MAPT (0.34) | ALDH1A1 | |
| SCHEMBL11853374 | 0.76 | S1PR2 (0.35) | ALDH1A1 | |
| SCHEMBL6791945 | 0.74 | MEN1 (0.33) | — | |
| SCHEMBL8351928 | 0.74 | MAPT (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113429361-B | Preparation method of tris (N-1, 4-dimethylpentyl p-phenylenediamine) -1,3, 5-triazine and intermediate thereof | 山东阳谷华泰化工股份有限公司 | 2022-08-26 | — | — | CN | claimed |
| CN-113563276-B | Preparation method of anti-aging agent TAPDT and intermediate thereof | 山东阳谷华泰化工股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-113429361-B | Preparation method of tris (N-1, 4-dimethylpentyl p-phenylenediamine) -1,3, 5-triazine and intermediate thereof | 山东阳谷华泰化工股份有限公司 | 2022-08-26 | — | — | CN | disclosed |
| US-7507818-B2 | Method for the production of alkoxycarbonylaminotriazines | BASF AKTIENGESELLSCHAFT (DE) | 2009-03-24 | — | — | US | disclosed |
| US-20060069254-A1 | Method for the production of alkoxycarbonylamino triazines | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-30 | — | — | US | disclosed |
| US-5086172-A | Reacting 2,4,6-trihalogeno-1,3,5-triazine with alkali or alkaline earth metal cyanide | BAYER AKTIENGESELLSCHAFT (DE) | 1992-02-04 | — | — | US | disclosed |
| EP-0436915-A2 | Process for the preparation of 2,4,6-tricyano-1,3,5-triazine | BAYER AG (DE) | 1991-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069254-A1 | Method for the production of alkoxycarbonylamino triazines | ADH1C, ADH5, ADH1A | ALDH1A1 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.